Cure8

Why This Matters

The study describes a mechanism by which Huaier granules reduced colitis-related inflammation in mice and cell models by targeting macrophage cGAS–STING signaling and altering the gut microbiome—information that could guide future translational research.

Who Should Pay Attention

Researchers in IBD immunology and microbiome, clinicians following experimental IBD therapies, and patients interested in preclinical research on herbal remedies

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This is a preclinical mechanistic study using DSS-colitis mice, single-cell RNA sequencing, macrophage and epithelial cell assays, and microbiome/SCFA analysis.

The authors report that Huaier reduced macrophage-related inflammatory signaling, limited monocyte-to-macrophage differentiation, improved markers of barrier integrity, and changed gut microbiota and SCFA levels. STING activation (cGAMP) partially reversed Huaier’s protective effects in the models used, supporting involvement of the cGAS–STING pathway.

The work helps explain a possible biological mechanism for a traditional medicinal fungus and identifies pathways and microbial changes that could be explored in future translational research. It does not provide clinical evidence that Huaier is safe or effective for people with IBD.

Keep In Mind

Results come from DSS mouse models, single-cell sequencing, and in vitro assays; these are mechanistic, preclinical findings and are not evidence of clinical benefit or safety in people with IBD.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationJournal of ethnopharmacology
AuthorsYuzhe Zhang, Fang Li, Jianzhong Liang +5 more
InstitutionThe First Laboratory of Cancer Institute, The First Hospital of China Medical University, Shenyang, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 22, 2026, 12:00 AM
Content availableJournal abstract

Conflict statement: Declaration of Competing Interest All authors declare that no actual or potential conflict of interest exists in relation to this work, including: Financial interests (e.g., funding, employment, patents, stock ownership), Non-financial interests (e.g., personal relationships, affiliations, or academic competition), and Influences from commercial entities related to drugs, materials, or methodologies described herein.

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →